These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21933835)

  • 1. Bioavailability of inhaled fluticasone propionate via chambers/masks in young children.
    Blake K; Mehta R; Spencer T; Kunka RL; Hendeles L
    Eur Respir J; 2012 Jan; 39(1):97-103. PubMed ID: 21933835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung bioavailability of hydrofluoroalkane fluticasone in young children when delivered by an antistatic chamber/mask.
    Khan Y; Tang Y; Hochhaus G; Shuster JJ; Spencer T; Chesrown S; Hendeles L
    J Pediatr; 2006 Dec; 149(6):793-7. PubMed ID: 17137894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate.
    Allen A; Bareille PJ; Rousell VM
    Clin Pharmacokinet; 2013 Jan; 52(1):37-42. PubMed ID: 23184737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A; Menzies D; Hopkinson P; McFarlane L; Lipworth BJ
    Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in inhaled fluticasone bioavailability between holding chambers in children with asthma.
    Liang J; Asmus MJ; Hochhaus G; Chesrown S; Hendeles L
    Pharmacotherapy; 2002 Aug; 22(8):947-53. PubMed ID: 12173797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer.
    Mehta R; Montembault M; Warren F; Gupta A; Brealey N; Moore A
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):386-92. PubMed ID: 26824933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
    Vutikullird AB; Gillespie M; Song S; Steinfeld J
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
    Purucker ME; Rosebraugh CJ; Zhou F; Meyer RJ
    Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers.
    Asmus MJ; Liang J; Coowanitwong I; Vafadari R; Hochhaus G
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):204-8. PubMed ID: 11868926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C; Li B; Tattam B; Brown K; Seale JP; Donnelly R
    Br J Clin Pharmacol; 2000 Aug; 50(2):116-24. PubMed ID: 10930963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
    Mackie AE; McDowall JE; Falcoz C; Ventresca P; Bye A; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.
    Dalby C; Polanowski T; Larsson T; Borgström L; Edsbäcker S; Harrison TW
    Respir Res; 2009 Oct; 10(1):104. PubMed ID: 19878590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler.
    Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
    J Aerosol Med; 2002; 15(4):427-33. PubMed ID: 12581509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
    Dempsey OJ; Humphreys M; Coutie WJ; Lipworth BJ
    Eur J Clin Pharmacol; 2001 Nov; 57(9):637-41. PubMed ID: 11791892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
    Bateman ED; Silins V; Bogolubov M
    Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma.
    Nugent C; Yiu G; Song S; Caracta C
    J Asthma; 2018 Aug; 55(8):898-906. PubMed ID: 28933971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
    Falcoz C; Horton J; Mackie AE; Harding SM; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.